On World TB day WHO calls for increased investments into TB services and research

by Public Health Update March 24, 2022

21 March 2022 News release

On World TB Day, WHO calls for an urgent investment of resources, support, care and information into the fight against tuberculosis (TB). Although 66 million lives have been saved since 2000, the COVID-19 pandemic has reversed those gains. For the first time in over a decade, TB deaths increased in 2020. Ongoing conflicts across Eastern Europe, Africa and the Middle East have further exacerbated the situation for vulnerable populations.

Global spending on TB diagnostics, treatments and prevention in 2020 were less than half of the global target of US$ 13 billion annually by 2022. For research and development, an extra US$ 1.1 billion per year is needed. “Urgent investments are needed to develop and expand access to the most innovative services and tools to prevent, detect and treat TB that could save millions of lives each year, narrow inequities and avert huge economic losses,” said Dr Tedros Adhanom Ghebreyesus. “These investments offer huge returns for countries and donors, in averted health care costs and increased productivity.”

Investments in TB programmes have demonstrated benefits not just for people with TB but for health systems and pandemic preparedness. Building on lessons learnt from COVID-19 research, there is a need to catalyse investment and action to accelerate the development of new tools, especially new TB vaccines.

Progress towards reaching the 2022 targets set in the UN High Level Meeting political declaration and the WHO Director-General’s Flagship Initiative Find.Treat.All is at risk mainly due to lack of funding. Between 2018–2020, 20 million people were reached with TB treatment. This is 50% of the 5-year target of 40 million people reached with TB treatment for 2018-2022. During the same period 8.7 million people were provided TB preventive treatment. This is 29% of the target of 30 million for 2018-2022.

The situation is even worse for children and adolescents with TB. In 2020, an estimated 63 % of children and young adolescents below 15 years with TB were not reached with or not officially reported to have accessed life-saving TB diagnosis and treatment services; the proportion was even higher – 72% – for children under 5 years. Almost two thirds of eligible children under 5 did not receive TB preventive treatment and therefore remain at risk of illness.

COVID-19 has had a further negative and disproportionate impact on children and adolescents with TB or at risk, with increased TB transmission in the household, lower care-seeking and access to health services. WHO is sounding the alarm on World TB Day for countries to urgently restore access to TB services, disrupted due to COVID-19 pandemic for all people with TB, especially children and adolescents.

“Children and adolescents with TB are lagging behind adults in access to TB prevention and care”, said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme. “The WHO guidelines issued today are a gamechanger for children and adolescents, helping them get diagnosed and access care sooner, leading to better outcomes and cutting transmission. The priority now is to rapidly expand implementation of the guidance across countries to save young lives and avert suffering”

Updated guidelines for the management of TB in children and adolescents

Updated guidelines for the management of TB in children and adolescents released by WHO today highlight new patient-centred recommendations for diagnosis, treatment and prevention. The most recent recommendations are:

Diagnostic testing has expanded to include non-invasive specimens, such as stools.
Rapid molecular diagnostics are recommended as the initial test for TB diagnosis for children and adolescents.
Children and adolescents who have non-severe forms of drug-susceptible TB are now recommended to be treated for four months instead of six months, as well as TB meningitis, where a six-month regimen is now recommended instead of 12 months. This promotes a patient-centred approach that will reduce the costs of TB care for children, adolescents and their families.
Two of the newest TB medicines to treat drug resistant TB (bedaquiline and delamanid) are now recommended for use in children of all ages, making it possible for children with drug-resistant TB to receive all-oral treatment regimens regardless of their age.
New models of decentralized and integrated TB care are also recommended, which will allow more children and adolescents to access TB care or preventive treatment, closer to where they live.

TB remains one of the world’s deadliest infectious killers. Each day, over 4 100 people lose their lives to TB and close to 30 000 people fall ill with this preventable and curable disease. Ending TB requires concerted action by all sectors. On World TB Day, WHO calls on everyone- individuals, communities, societies, donors and governments to do their part to end TB.

21 March 2022 News release

WHO Calls for Urgent, Sustained and Adequate Investments in Ending TB

by Public Health Update March 23, 2022

written by Public Health Update

Media statement on World TB Day, 24 March 2022
Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia

Invest to End TB. Save Lives On World TB Day, WHO is highlighting the urgent need for national, international and global stakeholders to invest at least US$ 3 billion annually in the South-East Asia Region to avert nearly 4.5 million new TB cases and prevent more than 1.5 million TB deaths by 2025. Globally, TB kills more than 4100 people every day. It makes close to 28,000 sick. In 2020, amid the COVID-19 response, TB caused an estimated 1.5 million deaths globally, up from 1.4 million in 2019. In the Region, estimated TB and TB-HIV mortality increased by nearly 10% in 2020, to over 700,000 lives lost – a trend that is likely to continue, if not worsen, unless urgent action is taken. In all countries of the Region, WHO continues to accelerate efforts to end TB, in line with its Flagship Priorities, the global End TB Strategy, the UN Political Declaration on the Fight Against TB, and Sustainable Development Goal target 3.3.

The Region continues to galvanize political momentum to achieve the End TB milestones. In October 2021, India, Indonesia and Nepal co-hosted a high-level meeting at which Member States committed to renew the TB response, building on the legacy of the 2018 Delhi End TB Summit and the Region’s Statement of Action. At the meeting, Member States endorsed a new Regional Strategic Plan (2021–2025), which among other features, provides a detailed account of funding shortfalls for priority interventions. Between 2015 and 2021, domestic budgets for national TB programmes tripled, from US$ 168 million to US$ 558 million.Throughout the COVID-19 response, countries have made commendable efforts to maintain essential health services, including for TB. In 2020, India launched a “Jan Andolan”, or people’s movement, against TB.

In 2021, Indonesia issued a Presidential Decree to End TB, while both Nepal and Timor-Leste launched high-level initiatives to accelerate towards the End TB milestones.

Achieving the Region’s US$ 3 billion annual investment target is especially important given the impact of the COVID-19 pandemic. In addition to the 10% increase in TB mortality in the Region in 2020, case notification dropped from 3.6 million to 2.6 million – the same level as in 2015. After five years of growth, the Region suffered an economic contraction of -5.4% pushing tens of millions of people into extreme poverty and exacerbating the social determinants of health. In 2019 almost 23% of new TB cases in the Region were attributable to undernutrition, which has since intensified among the poorest and most vulnerable. In all countries of the Region, social and economic support for TB patients must be enhanced, better integrated into social protection services, and delineated into measures that are TB-specific, TB-inclusive and TB-sensitive.

In the months and years ahead, the Region has several priorities.First, translating political momentum into on-the-ground action and results. To do that, WHO will support Member States to operationalize empowered TB mechanisms based on the principles of the multi-stakeholder accountability framework for TB.Second, increasing human resource allocations and engaging all care providers. Not only will this reduce TB mortality itself, but also increase the strength and reach of key TB interventions, from active case-finding and contact-tracing, to the provision of TB preventive therapy, improved support for TB treatment adherence, and a rapid vaccine roll-out as soon as next-generation TB vaccines are developed and approved for use.Third, intensifying community engagement in planning, monitoring and implementing national TB programmes, ensuring that TB services are close to where people live and work and sensitive to their needs.Fourth, strengthening ongoing research, including Phase 3 clinical trials of a TB preventive vaccine for household contacts of TB patients, as well as a post-TB vaccine to prevent TB recurrence. Increased South-South collaboration for technology transfer and commodity support is especially needed. Our momentum must not be halted. Since 2017, accelerating efforts to end TB by 2030 has been one of eight Flagship Priorities in the Region.

Amid the COVID-19 response, and in the recovery that will follow, it will continue to be a critical concern. Increased investments in ending TB will not only avert new TB cases and deaths, but also avoid the loss of more than 31 million disability-adjusted life years in the Region between now and 2025. Across the Region, traditional and innovative financing mechanisms must be explored. Our network of TB financing agencies must be expanded. Together, we must achieve the highest attainable standards of rights-based, stigma-free, quality-assured, people-centric TB preventive, diagnostic, treatment, rehabilitative and palliative care.

On World TB Day, WHO calls for urgent, sustained and adequate investments in ending TB to save lives and secure a more equitable and sustainable future for all.

National Tuberculosis Control Centre (NTCC)

World Tuberculosis Day 2022: Invest to End TB. Save Lives

by Public Health Update March 22, 2022

written by Public Health Update

Overview

World Tuberculosis Day (World TB Day) is celebrated each year on March 24 to raise public awareness and understanding about tuberculosis.

Objective

The main objective of World tuberculosis Day is to educate the public about the impact of TB around the world. It is an opportunity to raise awareness about the burden of tuberculosis (TB) worldwide and the status of TB prevention and care efforts. It is also an opportunity to mobilize political and social commitment for further progress in efforts to end TB.

World TB Day 2022

The theme of World TB Day 2022 – ‘Invest to End TB. Save Lives.’ –conveys the urgent need to invest resources to ramp up the fight against TB and achieve the commitments to end TB made by global leaders.

This is especially critical in the context of the COVID-19 pandemic that has put End TB progress at risk, and to ensure equitable access to prevention and care in line with WHO’s drive towards achieving Universal Health Coverage.

World Tuberculosis Day 2022 — World TB Day

Facts

66,000,000 lives saved since 2000 by global efforts to end TB
9,900,000 people fell ill with TB in 2020
1,500,000 people died of TB in 2020
In 2020, an estimated 10 million people fell ill with tuberculosis(TB) worldwide. 5.6 million men, 3.3 million women and 1.1 million children. TB is present in all countries and age groups. But TB is curable and preventable.
A total of 1.5 million people died from TB in 2020 (including 214 000 people with HIV). Worldwide, TB is the 13th leading cause of death and the second leading infectious killer after COVID-19 (above HIV/AIDS).
In 2020, the 30 high TB burden countries accounted for 86% of new TB cases. Eight countries account for two thirds of the total, with India leading the count, followed by China, Indonesia, the Philippines, Pakistan, Nigeria, Bangladesh and South Africa.
In 2020, 1.1 million children fell ill with TB globally. Child and adolescent TB is often overlooked by health providers and can be difficult to diagnose and treat.
TB is the leading killer of people with HIV. In 2020, there were 375 962 people who had TB and HIV were notified, of whom 88% were on antiretroviral therapy. Most of the gaps in detection and treatment were in the WHO African Region, where the burden of HIV associated TB is highest.
Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat. Only about one in three people with drug resistant TB accessed treatment in 2020. In some cases an even more severe form of multi-drug resistant TB may develop with bad treatment. Pre-extensively drug-resistant TB (pre-XDR-TB) and (XDR-TB) are forms of TB that responds to even fewer available medicines.
TB treatment saved about 66 million lives globally between 2000 and 2020, but important diagnostic and treatment gaps persist. The treatment success rate for people with TB was 86% in 2019.
Globally, TB incidence is falling at about 2% per year (1.9% from 2019 to 2020). This is much slower than the 4–5% annual decline that was required to achieve the 2020 milestones of the WHO End TB Strategy.
Funding for the provision of TB prevention, diagnostic and treatment services increased from 2010 to 2019, but spending in low and middle-income countries fell from US$ 5.8 billion in 2019 to US$5.3 billion in 2020. This falls far short of the target of US$13 billion per year by 2022 that was set at the first UN high-level meeting on TB. For research and development, at least an extra US$ 1.1 billion per year is needed to accelerate the development of new tools.

Source of Info: World Health Organization, STOP TB, Global Tuberculosis Report 2020, Global Tuberculosis Report 2021.

National Tuberculosis Control Centre (NTCC)

World Oral Health Day 2022: Be Proud of Your Mouth for your happiness and well-being

by Public Health Update March 20, 2022

written by Public Health Update

Background

Oral diseases are a major health concern for many countries and negatively impact people throughout their lives. Oral diseases lead to pain and discomfort, social isolation and loss of self-confidence, and they are often linked to other serious health issues. And yet, there is no reason to suffer: most oral health conditions are largely preventable and can be treated in their early stages.

World Oral Health Day 2022: Be Proud of Your Mouth for your happiness and well-being

This year, help us spread the word to encourage as many people as possible to look after their mouth and protect their quality of life. Because an unhealthy mouth not only impacts general health but it can have a severe impact on people’s emotional, social, mental, and overall physical well-being; and that’s why we are calling on people to Be Proud of their Mouth for their happiness and well-being.

Facts

Oral Diseases affect nearly 3.5 billion people globally.
More than 530 million children suffer from Tooth Decay in their Primary Teeth, which can lead to pain, infection, Tooth Loss and missed school days.
There is so much everyone can do to reduce their risk of Oral Diseases as well as other serious health conditions.
Good oral hygiene habits learned at a young age will help keep a child’s mouth healthy throughout life.
Tooth Decay is preventable, yet millions of people suffer because of it. Be Proud of Your Mouth.
Oral Health is vital for your happiness and well-being. The good news is that oral health can be maintained by being aware of your risk factors and taking action to prevent disease.
Practicing a good oral hygiene routine at home, combined with regular visits to the dentist, is one of the most important things you can do for your oral and overall health.

World Oral Health Day

[MEC id=”77146″]

March 20, 2022 1 comment

PhD European Region International Jobs & Opportunities Public Health Opportunities Public Health Opportunity

Declaration of interest regarding PhD project, University of Southern Denmark (SDU)

by Public Health Update March 20, 2022

written by Public Health Update

Psychiatric Research Unit, Department of Psychiatry, University Hospital Southern Denmark and Institute of Clinical Research, University of Southern Denmark (SDU) is looking for applicants for a PhD scholarship within the field of epidemiology, reproduction, and mental health.

Research environment

The candidate will join a research group at Psychiatric Research Unit, Department of Psychiatry, University Hospital Southern Denmark and Institute of Clinical Research, University of Southern Denmark (SDU), and be affiliated with the pharmacoepidemiology group at Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Denmark.

Jointly these research environments will provide the fundaments for the PACE project representing expertise in perinatal mental health, reproductive and psychiatric epidemiology, as well as pharmacoepidemiology and method development.

Project description

Postpartum depression (PPD) is observed in 10-15% of all new mothers, directly inferring PPDs are triggered by some component either of pregnancy, delivery, or the postpartum period. However, it is not clear to which extent the biological aspect of pregnancy and childbirth vs. the psychological impact of motherhood explains PPD risk, and further how genetic vulnerability or environmental factors individually or in combination explain the increased risk of PPD.

The PACE project will apply a triangulation approach to understand the underlying causality and etiology behind PPD. Leveraging the unique Danish registers, we will address why motherhood is associated with increased risk of depression including unique study designs, including a twin study, a natural experiment and applying the use of negative controls.

The PACE project is funded by Novo Nordisk Foundation and among others covers a fully funded 3-year PhD position. The applicant is however expected to apply for own funding to cover costs related to research stay at another research institution and costs related to conference participation.

The outlined work for the PhD project will be done by the PhD candidate in collaboration and after coordination with co-supervisors (to be determined) and professor Trine Munk-Olsen (main supervisor). More specifically, the project should focus on to which extent is biology of pregnancy and childbirth related to risk of PPD and consider how genetic vulnerability (measured as family history of various mental disorders) influence PPD risk.

Specific studies could focus on:

Comparison of risk of PPD in mothers having a biological child vs. mothers adopting a child
Comparison of risk of and risk factors for PPD in mothers vs. fathers
Risk of PPD in mothers with family history of PPD, depression or PTSD

Qualifications

We are looking for a candidate with a master’s degree in health science, public health, pharmacology, or similar degrees. Students expecting to finish their degree in the summer (2022) are also invited to apply.

We invite motivated candidates with interest in quantitative research within the field of epidemiology and mental health to apply and will specifically look for candidates with documented experience in research and scientific manuscript writing, as well as interests and/or hands-on experience with e.g., systematic reviews or meta-analyses, register-based research and coding/statistical analyses in e.g. Stata.

The successful applicant will join a new dynamic research team with both national and international collaborators and will be introduced and included in relevant discussions, research projects and collaborations.

Suitable candidates will be invited for an informal interview after the application deadline.

For further information about the project, please contact:

Professor Trine Munk-Olsen
Psychiatric Research Unit
Department of Psychiatry, University Hospital Southern Denmark
Institute of Clinical Research
University of Southern Denmark (SDU)

Phone number: +45 24 46 62 97
E-mail: tmun@sdu.dkApplications must include:

At letter stating the interest, motivation, and qualifications for the project (max. 2 pages) – upload under “Application form”.
Detailed CV, including personal contact information
Certified copy of diploma (Master’s degree in a relevant field)

Applications must be submitted electronically using the link “Apply online”.

Attached files must be in Adobe PDF or Word format. Each box can only contain a single file of max. 10 Mb.

Incomplete applications and applications received after the deadline will neither be considered nor evaluated. This also applies to reference letters.

Application deadline: April 4, 2022.

Successful candidates will be asked to send an application to the PhD Secretariat, Faculty of Health Sciences, to be enrolled as PhD students.

The PhD programme will be carried out in accordance with Faculty regulations and the Danish Ministerial Order on the PhD Programme at the Universities (PhD order)

The terms of employment as a salaried PhD Research Fellow are stated in the Agreement between the Ministry of Finance and the Danish Confederation of Professional Associations (AC).

The University wishes our staff to reflect the diversity of society and thus welcomes applications from all qualified candidates regardless of personal background.

Read more and apply

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated

March 20, 2022 0 comments

Public Health Opportunity Call for Proposal, EOI & RFP Public Health Opportunities

Call for applications for members to serve on Strategic and Technical Advisory Group on Tuberculosis (STAG-TB)

by Public Health Update March 14, 2022

written by Public Health Update

Call for applications for members to serve on Strategic and Technical Advisory Group on Tuberculosis (STAG-TB)

14 March 2022 (Call for experts)

The World Health Organization’s (WHO) Global Tuberculosis (TB) Programme is seeking qualified individuals to serve as members of the Strategic and Technical Advisory Group on Tuberculosis (STAG-TB). This “Call for experts” provides information about the above advisory group, the expert profiles being sought, the process to express interest, and the process of selection.

Background

As part of the United Nations Sustainable Development Goals and WHO’s End TB Strategy, Member States committed to ending the global TB epidemic by 2030. The first United Nations high-level meeting on TB held in 2018 resulted in a political declaration with ambitious targets and commitments to contribute to this goal. The UN Secretary General’s 2020 progress report for this political declaration noted that the high-level commitments and targets have galvanized global and national progress towards ending TB, but urgent and more ambitious investments and actions are required, especially in the context of the COVID-19 pandemic. The pandemic has resulted in an annual increase in the number of people dying from TB for the first time in a decade, coupled with reductions in the number of people diagnosed and treated for TB.

WHO is committed to working with countries, partners and civil society in ensuring access to TB prevention and care services. The Strategic and Technical Advisory Group for Tuberculosis was established in 2001 and provides advice to WHO on ending TB.

Operations and membership of the STAG-TB

Members of the STAG-TB are appointed by the Director-General based on their scientific and technical competence. In the selection of the members, consideration is given to attaining a balance of technical expertise as well as geographical and gender representation. Members serve in their personal capacities, for a term of three years, to represent the range of disciplines relevant to public policy development and implementation for ending TB.

STAG-TB meetings are organized annually, and ad-hoc meetings may be organized from time to time to address any urgent issues. Members may also be requested to provide input into online documents between scheduled meetings. The current membership and terms of reference of the STAG-TB are available here.

Who can express interest?

This call for expression of interest is open to experts with high-level experience and demonstrated results in providing strategic leadership on public health and global development. We are inviting experts in the following areas to complement the existing STAG-TB membership: governance, financing, ethics, human rights, social protection and multisectoral collaboration. Given the need for multisectoral action to combat TB, as outlined in the UN High Level Meeting Political Declaration and SDGs, special consideration will be given to applicants with expertise beyond TB. As the distribution of the global burden of tuberculosis, expertise and experience relevant to low- and middle- income settings is particularly important.

Submitting your expression of interest

To register your interest to be considered for the STAG-TB, please submit the following documents by 25 March, 2022 to gtbprogramme@who.int, using the subject line “Expression of interest for the STAG-TB”:

· A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore, do not use the letterhead or other identification of your employer;

· Please include in the cover letter, the primary and secondary (if any) workstream(s) you would like to be considered for (i.e. monitoring and surveillance, operational research, affected communities and civil society engagement, health system strengthening, wider global health issues) and describe any content areas in which you have particular interest and expertise (e.g. such as health care financing, ethics, human rights, and social protection, palliative care, disability, mental health);

· Your curriculum vitae;

· A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at here.

The 2022 STAG-TB meeting is scheduled for 6-8 June 2022 in Geneva, Switzerland; interested individuals should be available for this meeting.

After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed.

Important information about the selection processes and conditions of appointment

Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of an AG is, among other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts. AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG.

The selection of members of the AGs will be made by WHO in its sole discretion, taking into account the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations. The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of a AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents.

WHO reserves the right to accept or reject any expression of interest to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing TAG or modify the work of the AG.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

Official info: WHO

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

March 14, 2022 0 comments

Courses Implementation Research Online & Distance Learning Online Courses

Massive open online course (MOOC) Implementation Research 2022

by Public Health Update March 14, 2022

written by Public Health Update

Overview

A new session of the TDR Massive Open Online Course (MOOC) is the Implementation Research on infectious diseases in the low/middle-income countries at WHO-SEARO and WHO-WPRO organized by WHO in collaboration with the Center for Tropical Medicine UGM as a regional training center supported by the Special Program for Research and Training in Tropical Diseases (TDR).

This course is provided free of charge to introduce participants to Implementation Research to provide proven health interventions needed for people at risk and vulnerable to poverty. The 5 participants/teams with the best applications will be awarded a grant to carry out their research project.

Application process

All participants with various educational backgrounds can participate in this course. However, a health education background will be prioritized. Applications are accepted until March 29, 2022, and the course will start on April 18, 2022. Registration can be sent via email to yasinta.zulaikha@mail.ugm.ac.id

March 14, 2022 0 comments

Reports Research & Publication

Lumbini Province Annual Health Report 2077/078

by Public Health Update March 13, 2022

written by Public Health Update

Overview

The Annual Report of the Lumbini Province, Ministry of Health, Population and Family Welfare, Health Directorate, for fiscal year 2077/078 is the fourth consecutive report after its establishment. The report mentions the health programs’ aims, targets, and strategies, as well as their significant achievements and trends in service coverage during three fiscal years in the province. This report also outlines difficulties, problems, and constraints, as well as activities that health institutions can take to enhance their performance.

Highlights

The provincial coverage of BCG was 94.1% which has increased by 2.3 % point from 2076-77 to FY 2077-78.
MR2 coverage (94.1%).
Eleven of the province’s 12 districts have been declared fully immunized by the end of FY 2077-78.
In Lumbini 20 hospitals have been providing CEONC services and there are 32 BEONC service sites and 406 birthing centers.
Provincial level ANC 4th visit (as per protocol) as percentage of expected pregnancy was 60.7%. The proportion of births attended by SBA has decreased slightly from 78.5% in FY 2076-77 to 77% in FY 2077-78.
Percentage of institutional deliveries in Lumbini province in FY 2077-78 was 79.6%.
Provincial mCPR has dropped from 43 to 36% between FY 2075-76 to FY 2077-78. The mCPR is either stagnant or declining steadily in most of the district.
In the fiscal year 2077-78, 150 health facilities in Lumbini provided at least one safe abortion service. Rukum -East does not have any safe abortion service sites, whereas Palpa has the most (23) safe abortion service sites.
In fiscal year 2077-78 three health facilities in Lumbini province, received certification for adolescent friendly health facility from the Family Welfare Division.
Confirmed malaria cases decreased from 219, 141 and 85 in 2075-76, 2076-77 and 2077-78 respectively.
At the end of FY2077-78 (2020/21), 518 leprosy cases were receiving MDT in Lumbini Province which makes a registered prevalence rate of 1.01 per 10,000 populations at the Provincial Level.
This rate is above the cut-off point of 1 case per 10,000 set by WHO to indicate the elimination of leprosy as a public health problem.
The case notification rate (all forms) of Lumbini Province in 2077-78 is 113.9/100,000 population which was slightly increased than previous fiscal year. The district having highest CNR is Dang (137.8) and with lowest CNR is Gulmi (71.2) and there are nearly half of districts having CNR less than 100/100,000 population.
Provincial TB treatment success rate of TB in 2077-78 was 90.2 percent which is decreased from 93.2 of last fiscal year but treatment success rate (TSR) has been maintained as per National Strategic targets of TSR at least 90% in each year.
The TB mortality rate is slightly increased into 4.1% than last fiscal year which was 3.6%.
Overall DR TB treatment success rate is 76 %.
In FY 2077-78, URTI ranked highest morbidities in Lumbini province in past three years followed by Gastritis and Headache and the cases related to backache and hypertension has increased in this FY 2077-78 when comparing to FY 2075-76.
Bed occupancy rate has reached to 51.3 in FY 2077-78 which was 30.5 in FY 2076-77.
MSS has been implemented among 19 hospitals including local and federal level hospitals. All hospital of Lumbini province except Rukum west has implemented MPDSR program.
The total maternal mortality is 72 in Lumbini province of which 49 death is reported from hospital.
Only 46% of human resources were fulfilled against the sanctioned position.
There are nine Clinical training sites in Lumbini Province to deliver different clinical and competency-based trainings.

Chapter 1: Introduction

Background
Organizational Structure of Ministry of Health, Population and Family Welfare
Functions of Ministry of Health Population and Family Welfare
Organogram of Health Directorate
Health Service Delivery Units
Sources of Information in the Report
Structure of the Report

Chapter 2: Family Welfare

Child Health and Immunization

Integrated Management of Neonatal and Childhood Illnesses
Nutrition
Safe Motherhood and Newborn Health
Family Planning
Safe Abortion
Adolescent Sexual and Reproductive Health

Chapter 3: Epidemiology and Disease Control

Tuberculosis Control Program
HIV/AIDS and STI Control Program
Malaria Control Program
Dengue
Leprosy
Kala-azar
Lymphatic Filariasis

Chapter 4: Hospital Services

Background
Hospital Management Strengthening Program
Outpatients and Inpatient Services
Emergency Services
Radiology Services
Major and Minor Surgeries conducted by hospitals
Postmortem conducted in hospital
Maternal and Perinatal Death Surveillance and Response

Chapter 5: Social Security and Other Public Health Programs

One-Stop Crisis Management Center
Social Service Unit (SSU)
Suicide Prevention
Financial assistance program for the treatment of asthma and bronchitis of poor citizens
Home-based treatment to citizens above 84 years of age
Road Traffic Accidents

Chapter 6: COVID 19 Emergency and Response

Background of COVID 19
COVID 19 Situation in FY 2076-77 & 2077-78 at Lumbini Province
Strategic approaches and key interventions

Chapter 7: Supporting Programs

Health Service Governance and Management
Health Information Management
Human Resource for Health
Logistic Management
Health Training

Chapter 8: Ayurveda and Alternative Medicine

Chapter 9: Performance Evaluation

Chapter 10: Development Partners

DOWNLOAD PDF FILE

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

March 13, 2022 0 comments

Courses Online Courses Public Health Opportunities Public Health Opportunity

Enrolment open: AuthorAID Course on ‘Research Writing in the Sciences’

by Public Health Update March 9, 2022

written by Public Health Update

Who is this course for?
AuthorAID’s award-winning online courses are designed for researchers and scientists in low- and middle-income countries. This course is designed for those working in a scientific field (life sciences / natural sciences / other related fields). It is suitable for early career researchers, or those with limited experience in publishing papers in reputable peer-reviewed journals.

Course duration: 6 weeks

Main topics covered in the course:

Understanding previous research
Knowing the ethics of research
Preparing to write your research paper
Writing your research paper
Publishing your paper in a peer-reviewed journal

Course dates: 5th April to 16th May 2021

Course leaders: INASP team – Andy Nobes, Ravi Murugesan – along with experienced guest facilitators from the AuthorAID network.

How do I enrol?
Complete information about the course along with enrolment instructions are available on the INASP Moodle website: https://moodle.inasp.info/course/view.php?name=RW_Sci_2022. You will need to create an INASP Moodle account if you don’t already have one. Please follow the instructions carefully (you may need to click on the above link again after registering your account).

Please note that although this is an open course, we may have to limit enrolment due to server capacity. We suggest that you enrol in the course as soon as possible if you are interested.

INASP designs and runs capacity development activities that cater for both women and men’s interests and needs. We use methods that increase active participation and an inclusive learning environment, adopting attitudes and behaviours that value differential experiences and perspectives and ensuring listening and respect for each other’s experiences and views.

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

March 9, 2022 0 comments

Provincial Plan, Policies and Guidelines National Plan, Policy & Guidelines Research & Publication

Waling Municipality Public Health Act 2078

by Public Health Update March 7, 2022

written by Public Health Update

Office of Municipal Executive, Waling Municipality, Syangja has released it’s local public health act as per the mandate of Constitution of Nepal, Public Health Service Act, 2075 (2018), and Local Government Operation Act, 2074. Waling Municipality Public Health Act aims to guide and manage all public health related activities within Municipality. This act envisions to ensure the provision of free basic health care services to all citizens and provide emergency healthcare services as per the constitution of Nepal.

Establishment and management of health institutions, quality assurance, monitoring and supervision of local health activities and overall management of all public health activities in an integrated approach are incorporated within this document.

DOWNLOAD PDF FILE

Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

March 7, 2022 0 comments

Newer Posts

Older Posts

On World TB day WHO calls for increased investments into TB services and research

Updated guidelines for the management of TB in children and adolescents

Recommended readings

WHO Calls for Urgent, Sustained and Adequate Investments in Ending TB

Recommended readings

World Tuberculosis Day 2022: Invest to End TB. Save Lives

Overview

Objective

World TB Day 2022

Facts

Recommended readings

World Oral Health Day 2022: Be Proud of Your Mouth for your happiness and well-being

Background

Facts

Declaration of interest regarding PhD project, University of Southern Denmark (SDU)

Call for applications for members to serve on Strategic and Technical Advisory Group on Tuberculosis (STAG-TB)

Call for applications for members to serve on Strategic and Technical Advisory Group on Tuberculosis (STAG-TB)

Massive open online course (MOOC) Implementation Research 2022

Overview

Application process

Lumbini Province Annual Health Report 2077/078

Overview

Highlights

Contents

Enrolment open: AuthorAID Course on ‘Research Writing in the Sciences’

Waling Municipality Public Health Act 2078

PUBLIC HEALTH INITIATIVE